Prognostic value of the metastatic lymph node ratio in patients with pancreatic cancer.

Chengzhi He, Huisong Chen, Yingxin Wang, Changqing Yang, Hengjun Gao

Abstract read

In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Lymphatic metastasis in pancreatic cancer: from bedside to bench and back.Cancer metastasis reviews · 2025
Review
Prediction scores of postoperative liver metastasis and long-term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19-9 level, and lymph node metastasis rate.Cancer medicine · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chengzhi HeDepartment of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.

Huisong ChenDepartment of Gastroenterology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai 201999, China.

Yingxin WangDepartment of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.

Changqing YangDepartment of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.

Hengjun GaoDepartment of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, Tongji University School of Medicine Shanghai 200065, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study was to analyze the prognostic value of metastatic lymph node ratio (LNR) in pancreatic cancer (PC) patients undergoing surgical operation. We retrospectively reviewed 615 patients with PC who underwent surgical operation. The clinic-pathologic factors related to lymph node metastasis (LNM) were analyzed. There are 251 patients with LNM (40.8%), 364 cases of patients without LNM (59.2%). We found that overall survival (OS) of PC was significantly correlated to histological type, degree of differentiation, clinical staging, LNM, and LNR (all P < 0.05). Multivariate Cox regression analysis demonstrated that LNR was an independent risk factor for postoperative survival rate of patients with PC (P=0.006), and the presence of LNM was not an independent factor for predicting poor prognosis. When age and gender were included in multivariate Cox proportional hazards, LNR was still the independent prognostic factor for the OS of patients with PC (P=0.013). The value of LNR in the prediction of the prognosis of PC was better than the number and presence of LNM. It provided some helpful advice for clinicians to formulating a reasonable treatment strategy.

Indexed as

Lymphatic metastasisoutcomespancreatic cancerprognostic factors

Identifiers

PMID31933834

PMCPMC6949887

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.